Literature DB >> 26758972

ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum.

B Niederle1, U-F Pape, F Costa, D Gross, F Kelestimur, U Knigge, K Öberg, M Pavel, A Perren, C Toumpanakis, J O'Connor, D O'Toole, E Krenning, N Reed, R Kianmanesh.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26758972     DOI： 10.1159/000443170

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  97 in total

Review 1.  Echocardiography in functional midgut neuroendocrine tumors: When and how often.

Authors:  Javier G Castillo; Tara Naib; Jerome S Zacks; David H Adams
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 2.  Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2016-09-23       Impact factor: 3.889

3.  IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.

Authors:  Sara Massironi; Alessandro Del Gobbo; Federica Cavalcoli; Stefano Fiori; Dario Conte; Alessio Pellegrinelli; Massimo Milione; Stefano Ferrero
Journal:  Endocrine       Date:  2017-02-17       Impact factor: 3.633

Review 4.  Clinical pediatric positron emission tomography/magnetic resonance program: a guide to successful implementation.

Authors:  Sandra Saade-Lemus; Elad Nevo; Iman Soliman; Hansel J Otero; Ralph W Magee; Elizabeth T Drum; Lisa J States
Journal:  Pediatr Radiol       Date:  2020-02-19

5.  Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis.

Authors:  Diamantis I Tsilimigras; J Madison Hyer; Anghela Z Paredes; Aslam Ejaz; Jordan M Cloyd; Joal D Beane; Mary Dillhoff; Allan Tsung; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2021-01-05       Impact factor: 3.452

Review 6.  The Landmark Series: Neuroendocrine Tumor Liver Metastases.

Authors:  Alexandra Gangi; James R Howe
Journal:  Ann Surg Oncol       Date:  2020-07-06       Impact factor: 5.344

7.  Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.

Authors:  Diamantis I Tsilimigras; Ioannis Ntanasis-Stathopoulos; Ioannis D Kostakis; Demetrios Moris; Dimitrios Schizas; Jordan M Cloyd; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-01-22       Impact factor: 3.452

8.  Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.

Authors:  Marianne E Pavel; Alexandria T Phan; Edward M Wolin; Beloo Mirakhur; Nilani Liyanage; Susan Pitman Lowenthal; George A Fisher; Aaron I Vinik
Journal:  Oncologist       Date:  2018-10-24

Review 9.  The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

Authors:  M V Davi; A Pia; V Guarnotta; G Pizza; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2016-09-13       Impact factor: 4.256

10.  Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms.

Authors:  Maria Rinzivillo; Stefano Partelli; Daniela Prosperi; Gabriele Capurso; Patrizia Pizzichini; Elsa Iannicelli; Elettra Merola; Francesca Muffatti; Francesco Scopinaro; Orazio Schillaci; Matteo Salgarello; Massimo Falconi; Gianfranco Delle Fave; Francesco Panzuto
Journal:  Oncologist       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.